AstraZeneca计划到2030年向美国投资500亿美元, AstraZeneca plans to invest $50 billion in the U.S. by 2030 to boost domestic drug production.

AstraZeneca计划到2030年向美国投资500亿美元, 其中包括在弗吉尼亚州建造大型制造设施, AstraZeneca plans to invest $50 billion in the U.S. by 2030, including building a major manufacturing facility in Virginia focused on drugs for chronic diseases like obesity and hypertension. 这项投资旨在支持该公司实现到2030年达到800亿美元收入的目标,其中一半来自美国。 The investment aims to support the company's goal of reaching $80 billion in revenue by 2030, with half coming from the U.S. 在采取这一行动之后,其他制药公司也进行了类似的投资,以应对增加当地生产和减少对外国供应商依赖的压力。 This move follows similar investments by other pharmaceutical companies in response to pressures to increase local production and reduce reliance on foreign suppliers.